Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
NCT ID: NCT05908240
Last Updated: 2025-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
520 participants
INTERVENTIONAL
2023-06-15
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
NCT02144857
Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
NCT01522742
Subclinical Impairment of Cardiovascular System in Patients With Psoriasis
NCT05957120
Study of Psoriatic Arthritis
NCT00001420
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
NCT00893126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Care Coordination
Care Coordinator Model
A centralized care coordinator at the National Psoriasis Foundation will provide evidence-based education regarding a heart healthy lifestyle (i.e., diet, exercise, smoking cessation) and guidance from the American Heart Association/American College of Cardiology regarding management of dyslipidemia and hypertension. This information will be conveyed to a primary care provider of the patient's preference.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Care Coordinator Model
A centralized care coordinator at the National Psoriasis Foundation will provide evidence-based education regarding a heart healthy lifestyle (i.e., diet, exercise, smoking cessation) and guidance from the American Heart Association/American College of Cardiology regarding management of dyslipidemia and hypertension. This information will be conveyed to a primary care provider of the patient's preference.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male or female aged 40-75
3. Being seen by a dermatology provider in routine care for the primary encounter diagnosis of psoriasis
Exclusion Criteria
2. Pregnant or planning pregnancy in the next 6 months
3. Has a known history of cardiovascular disease (MI, Stroke, coronary artery, cerebrovascular, or peripheral vascular disease)
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Psoriasis Foundation
OTHER
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johnson Dermatology
Fort Smith, Arkansas, United States
Dawes Fretzin Clinical Research
Columbus, Indiana, United States
Dawes Fretzin Clinical Research
Indianapolis, Indiana, United States
MiSkinCenter
Northville, Michigan, United States
SUNY Downstate
Brooklyn, New York, United States
City Dermatology
Bensalem, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Utah
Salt Lake City, Utah, United States
University of Virginia
Charlottesville, Virginia, United States
Bellevue Dermatology Clinic
Bellevue, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Karen Garduza
Role: primary
Betty Uyesugi
Role: primary
Ashley Wallace
Role: primary
Jamie Szkodzinski
Role: primary
Tristi Edwards
Role: primary
Arslan Amir
Role: primary
Isaac Goddard
Role: primary
Lauren Khuns
Role: primary
Emily Leung
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
853218
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.